Nebcin and Arrhythmias - a phase IV clinical study of FDA data

Summary:

Arrhythmias is reported as a side effect among people who take Nebcin (tobramycin sulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tylenol, and have Pain.

The phase IV clinical study analyzes which people have Arrhythmias when taking Nebcin. It is created by eHealthMe based on reports of 217 people who have side effects when taking Nebcin from the FDA, and is updated regularly.

What is Nebcin?

Nebcin has active ingredients of tobramycin sulfate. eHealthMe is studying from 217 Nebcin users. Check the latest studies of Nebcin.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,760 drugs and 4,837 conditions by eHealthMe. Check the latest studies of Arrhythmias.

On Jul, 14, 2026

217 people reported to have side effects when taking Nebcin.
Among them, 13 people (5.99%) have Arrhythmias.

Among these 13 people:

How long have people been on Nebcin when they have Arrhythmias? *

What is the gender of people who have Arrhythmias when taking Nebcin? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Arrhythmias when taking Nebcin? *

What are other drugs people take besides Nebcin? *

What are other side effects people have besides Arrhythmias? *

White Blood Cell Count Increased: 5 people, 38.46%
Drug Dependence: 5 people, 38.46%
Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Liver Function Test Abnormal: 5 people, 38.46%
Insomnia (sleeplessness): 5 people, 38.46%
Weight Decreased: 5 people, 38.46%
Encephalopathy (functioning of the brain is affected by some agent or condition): 5 people, 38.46%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 5 people, 38.46%
Diarrhea: 5 people, 38.46%
Otitis Media (inflammation of the middle ear): 5 people, 38.46%

What are the existing conditions these people have? *

Pain: 6 people, 46.15%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 15.38%
Urinary Tract Infection: 1 person, 7.69%
Hypotension (abnormally low blood pressure): 1 person, 7.69%
Adjustment Disorder: 1 person, 7.69%
Anaemia (lack of blood): 1 person, 7.69%
Anaesthesia: 1 person, 7.69%
Constipation: 1 person, 7.69%
Cough: 1 person, 7.69%
Gastritis (inflammation of stomach): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nebcin and have Arrhythmias?

- Check whether Arrhythmias is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nebcin:

Nebcin (217 reports)

Arrhythmias treatments and more:

Arrhythmias (177,908 reports)

Browse all side effects of Nebcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arrhythmias:

Arrhythmias (2,760 drugs)

Browse all the conditions that are associated with Arrhythmias:

Arrhythmias (4,837 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin sulfate (the active ingredients of Nebcin) and Nebcin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.